Home › Funds › Flower City Capital › IMRX
Flower City Capital position in IMRX
IMMUNEERING CORP · Health Care
Flower City Capital reported holding 60,029 shares of IMRX (IMMUNEERING CORP) in its Q3 2026 13F filing — a position valued at US$246K, representing 0.11% of its reported portfolio and ranking #38 among its reported holdings. Flower City Capital has disclosed IMRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
Last updated: 2026-10-15 · Source: SEC EDGAR Form 13F-HR
How Flower City Capital's IMRX position evolved
Flower City Capital first disclosed a stake in IMRX in Q2 2025 at 32,029 shares (US$108K). The position peaked in Q1 2026 at 55,029 shares, worth US$290K. Across 6 filings, Flower City Capital increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 60,029 shares valued at US$246K — an increase of 5,000 shares quarter over quarter.. Notable position changes include a 44% increase in Q4 2025 (shares fell 20% over the following quarter), a 30% increase in Q1 2026 (shares fell 5% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2025 | 32.03K | $107.94K | New |
| Q3 2025 | 29.23K | $204.60K | Reduce |
| Q4 2025 | 42.23K | $277.87K | Add |
| Q1 2026 | 55.03K | $290.00K | Add |
| Q2 2026 | 55.03K | $274.60K | Hold |
| Q3 2026 | 60.03K | $245.82K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IMRX and 13F data
IMRX (IMMUNEERING CORP) is a Health Care company. 60 other funds we track also report a position in IMRX — the largest reported positions include Sanofi (US$13.5M), DCF Advisers, LLC (US$3.9M), ALETHEA CAPITAL MANAGEMENT, LLC (US$2.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IMRX
- Sanofi 2.71M sh · $13.52M · Q2 2026
- DCF Advisers, LLC 790.00K sh · $3.94M · Q2 2026
- ALETHEA CAPITAL MANAGEMENT, LLC 472.94K sh · $2.36M · Q2 2026
- Occam Crest Management LP 278.50K sh · $1.13M · Q2 2026
- BRANDYWINE MANAGERS, LLC 55.07K sh · $274.78K · Q2 2026
More on Flower City Capital
FAQ
How long has Flower City Capital held IMRX?
Flower City Capital has disclosed IMRX holdings in 6 of the last 6 reported quarters, going back to Q2 2025.
What is Flower City Capital's current position in IMRX?
As of Q3 2026, Flower City Capital holds 60.03K shares of IMRX (IMMUNEERING CORP), valued at $245.82K, representing 0.11% of its reported portfolio and ranking #38.
Has Flower City Capital been buying or selling IMRX?
In the latest 13F filing (Q3 2026), Flower City Capital increased its position in IMRX. The position peaked in Q1 2026 at 55.03K shares.
Which other funds hold IMRX?
Other major institutional holders of IMRX include Sanofi, DCF Advisers, LLC, ALETHEA CAPITAL MANAGEMENT, LLC, among 60 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.